#	Pagina
attuale pagina	/open-h2020/projects/198926/index.html
-1	/open-h2020/projects/210660/index.html
-2	/open-h2020/projects/197978/index.html
-3	/open-h2020/projects/216187/index.html
-4	/open-h2020/projects/218709/index.html
-5	/open-h2020/projects/204725/index.html
-6	/open-h2020/projects/223659/index.html
-7	/open-h2020/projects/212865/index.html
-8	/open-h2020/projects/206770/index.html
-9	/open-h2020/projects/213222/index.html

Opendata, web and dolomites

Infarnosys

Novel biomarker diagnostic system for the assessment of the prognosis of acute myocardial ischemia/reperfusion injury and infarction and the effectiveness of the treatment

Total Cost €

EC-Contrib. €

Partnership

Views

Outcomes and
results

Infarnosys project word cloud

Explore the words cloud of the Infarnosys project. It provides you a very rough idea of what is the project "Infarnosys" about.

disease men tested helps diagnose diseases deaths effectiveness sophisticated death launch cardiologists earlier start marker diagnosis women injury prognosticate patenting fact attack premature measuring nitrotyrosin inhibitors journal connected reperfusion performing strategy prepare samples heart 80 innovative published combined artery clinical investigation occurrence specify cardiac biomarker preventable levels reducing feasibility treatments laboratories cardiovascular coronary trial tests clinicians documentation combination treatment mmp market ischemia diagnostic predicting infarnosys blood

Project "Infarnosys" data sheet

The following table provides information about the project.

Coordinator	PHARMAHUNGARY 2000 KISERLETES ES KLINIKAI KUTATASFEJLESZTESI KORLATOLTFELELOSSEGU TARSASAG Organization address address: HAJNOCZY UTCA 6 1 EM 1 city: SZEGED postcode: 6722 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	Hungary [HU]
Project website	http://www.infarnosys.com/
Total cost	71˙429 €
EC max contribution	50˙000 € (70%)
Programme	1. H2020-EU.3.1.3. (Treating and managing disease)
Code Call	H2020-SMEINST-1-2015
Funding Scheme	SME-1
Starting year	2015
Duration (year-month-day)	from 2015-09-01 to 2016-02-29

Partnership

Take a look of project's partnership.

#	participants	country	role	EC contrib. [€]
1	PHARMAHUNGARY 2000 KISERLETES ES KLINIKAI KUTATASFEJLESZTESI KORLATOLTFELELOSSEGU TARSASAG PHARMAHUNGARY 2000 KISERLETES ES KLINIKAI KUTATASFEJLESZTESI KORLATOLTFELELOSSEGU TARSASAG Organization address address: HAJNOCZY UTCA 6 1 EM 1 city: SZEGED postcode: 6722 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	HU (SZEGED)	coordinator	50˙000.00

Map

Project objective

The Infarnosys project aims to launch a novel, combined biomarker diagnostic system on the market that will help clinicians and laboratories to earlier and better diagnose cardiac ischemia/reperfusion injury and prognosticate the effectiveness of the treatment. The innovative process measures MMP-2, MMP-9 and nitrotyrosin levels and tests MMP inhibitors in artery blood samples. Measuring MMP and nitrotyrosin levels enables predicting the occurrence of heart attack and helps to start the treatment much earlier. Testing MMP inhibitors on blood samples will help cardiologists to specify the treatments in a more sophisticated way.

For both men and women, coronary artery disease is the leading cause of death in Europe in spite of the fact that 80% of premature heart diseases are preventable. Earlier and better diagnosis of cardiac ischemia and reperfusion injury is crucial for reducing the number of deaths connected to cardiovascular diseases.

Our diagnostic marker combination has been tested already in a pre-clinical study and the results were published in the European Journal of Clinical Investigation. A Phase 2 project would aim a clinical trial and the Phase 1 feasibility study would prepare it by performing a market research including a market launch strategy and cost analysis, as well as it would prepare the clinical study documentation and the patenting process.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "INFARNOSYS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "INFARNOSYS" are provided by the European Opendata Portal: CORDIS opendata.